Stryker (SYK) Competitors

Stryker (NYSE:SYK) and Abbott Laboratories (NYSE:ABT) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their community ranking, institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations.

Is SYK or ABT more profitable?

Abbott Laboratories has a net margin of 31.95% compared to Stryker's net margin of 13.25%. Stryker's return on equity of 23.58% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stryker	13.25%	23.58%	11.37%
Abbott Laboratories	31.95%	20.74%	11.19%

Which has more volatility & risk, SYK or ABT?

Stryker has a beta of 0.93, indicating that its share price is 7% less volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Which has preferable valuation and earnings, SYK or ABT?

Abbott Laboratories has higher revenue and earnings than Stryker. Abbott Laboratories is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stryker	$22.60B	5.86	$2.99B	$7.76	44.70
Abbott Laboratories	$41.95B	5.21	$13.40B	$7.65	16.48

Is SYK or ABT a better dividend stock?

Stryker pays an annual dividend of $3.36 per share and has a dividend yield of 1.0%. Abbott Laboratories pays an annual dividend of $2.36 per share and has a dividend yield of 1.9%. Stryker pays out 43.3% of its earnings in the form of a dividend. Abbott Laboratories pays out 30.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Stryker has increased its dividend for 32 consecutive years and Abbott Laboratories has increased its dividend for 54 consecutive years. Abbott Laboratories is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Does the MarketBeat Community favor SYK or ABT?

Abbott Laboratories received 11 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 69.97% of users gave Abbott Laboratories an outperform vote while only 64.57% of users gave Stryker an outperform vote.

Company	Underperform	Outperform
Stryker	Outperform Votes 935 64.57%	Underperform Votes 513 35.43%
Abbott Laboratories	Outperform Votes 946 69.97%	Underperform Votes 406 30.03%

Do analysts rate SYK or ABT?

Stryker currently has a consensus price target of $423.05, indicating a potential upside of 21.96%. Abbott Laboratories has a consensus price target of $137.94, indicating a potential upside of 9.41%. Given Stryker's higher probable upside, equities analysts plainly believe Stryker is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stryker	0 Sell rating(s)	4 Hold rating(s)	15 Buy rating(s)	0 Strong Buy rating(s)	2.79
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.84

Do institutionals & insiders have more ownership in SYK or ABT?

77.1% of Stryker shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 5.9% of Stryker shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the media favor SYK or ABT?

In the previous week, Abbott Laboratories had 13 more articles in the media than Stryker. MarketBeat recorded 55 mentions for Abbott Laboratories and 42 mentions for Stryker. Stryker's average media sentiment score of 1.46 beat Abbott Laboratories' score of 1.36 indicating that Stryker is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stryker	34 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	39 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Stryker and Abbott Laboratories tied by winning 11 of the 22 factors compared between the two stocks.